180 Life Sciences Corp board member Sir Marc Feldmann resigns
Investing.com | Editor Ahmed Abdulazez Abdulkadir
Published Mar 11, 2024 08:33AM ET
In a recent development, Sir Marc Feldmann, Ph.D., has resigned from his position on the Board of Directors of 180 Life Sciences Corp (NASDAQ:ATNF), a biotechnology company focused on the development of novel therapies for inflammatory diseases, fibrosis, and pain. The resignation took effect immediately on Tuesday.
Sir Feldmann, a renowned immunologist and academic, provided his notice of resignation to the company's board on the same day. According to the statement released by 180 Life Sciences, there were no disagreements between Sir Feldmann and the company that prompted his departure. The company's operations, policies, and practices have not been cited as factors in the decision.
The announcement was made public through a filing with the Securities and Exchange Commission (SEC). The filing did not elaborate on the reasons behind Sir Feldmann's resignation or indicate any immediate plans for a replacement on the Board of Directors.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.
Get The News You Want
Written By: Investing.com
Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.